A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic ...